SCHEMBL3559657

SCHEMBL3559657

NC(=O)c1ccccc1-c1cccs1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
MAPT P10636 4/20 0.54
KDM4E B2RXH2 3/20 0.54
HPGD P15428 2/20 0.54
TSHR P16473 2/20 0.54
HSD17B10 Q99714 2/20 0.54
GAA P10253 2/20 0.54
BCAT2 O15382 1/20 0.53
AR P10275 1/20 0.48
BTK Q06187 1/20 0.44
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
CSNK1A1 P48729 1/20 0.42
TYRO3 Q06418 1/20 0.42
DYRK1B Q9Y463 1/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
NFKB1 P19838 1/20 0.42
RAB9A P51151 1/20 0.42
NFKB2 Q00653 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932848 0.83 ALOX15 (0.53) ALDH1A1MAPTKDM4EHPGDNPC1
SCHEMBL2417969 0.83 ALDH1A1 (0.49) ALDH1A1MAPTKDM4EHPGDTSHR
SCHEMBL6246471 0.81 MAPT (0.42) ALDH1A1MAPTKDM4EHPGDTSHR
SCHEMBL8109418 0.81 MAPT (0.42) ALDH1A1MAPTKDM4EHPGDTSHR
SCHEMBL1023432 0.81 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EHPGDTSHR
SCHEMBL11678330 0.81 HCRTR1 (0.44) ALDH1A1MAPTKDM4EHPGDTSHR
SCHEMBL28522655 0.81 KDM4E (0.53) ALDH1A1MAPTKDM4EHPGDTSHR
Zinc Ion SCHEMBL10405317 0.80 HCRTR1 (0.42) ALDH1A1MAPTKDM4EHPGDTSHR
SCHEMBL30344049 0.79 KDM4E (0.43) ALDH1A1MAPTKDM4EHPGDTSHR
SCHEMBL4089638 0.79 MYC (0.44) ALDH1A1MAPTKDM4EHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106831285-B Method for converting amide and urea into ester 湖北科技学院 2020-08-11 CN claimed
CN-101636073-A The seed of bag quilt and manufacturing bag are by the method for seed VAMTECH L L C 2010-01-27 CN claimed
EP-2035386-A1 ISOQUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF CYTOKINE MEDIATED DISEASES AstraZeneca AB (SE) 2009-03-18 EP claimed
WO-2007149031-A1 ISOQUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF CYTOKINE MEDIATED DISEASES ASTRAZENECA AB (SE) 2007-12-27 WO claimed
EP-1807406-A2 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP claimed
WO-2006047503-A2 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA (BE) 2006-05-04 WO claimed
US-20050113566-A1 Inhibitors of C-FMS kinase JANSSEN PHARMACEUTICA N.V. (BE) 2005-05-26 US claimed
US-20230116770-A1 SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute 2023-04-13 US disclosed
US-11452717-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof Sanford Burnham Prebys Medical Discovery Institute (US) 2022-09-27 US disclosed
CN-106831285-B Method for converting amide and urea into ester 湖北科技学院 2020-08-11 CN disclosed
EP-3568390-A1 SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2019-11-20 EP disclosed
WO-2018132372-A1 SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2018-07-19 WO disclosed
CN-105949161-B A kind of preparation method of 3- aromatic thiohydroxies chromocor compound 温州大学 2018-05-15 CN disclosed
US-20050113566-A1 Inhibitors of C-FMS kinase JANSSEN PHARMACEUTICA N.V. (BE) 2005-05-26 US disclosed
CN-1150198-C Process for producing hexahydrothiopheno-[3,4-d] imidazole-2,4-diketones compound 住友化学工业株式会社 2004-05-19 CN disclosed
CN-1277200-A Process for producing hexahydrothiopheno-[3,4-d] imidazole-2,4-diketones compound SUMITOMO KAGAKU KOGYO K K (JP) 2000-12-20 CN disclosed
EP-0804420-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS American Cyanamid Company (US) 1997-11-05 EP disclosed
US-4199360-A DISSOLVING METHINE DYE IN PRESENCE OF RED SHIFT COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1980-04-22 US disclosed
US-4138266-A SULFO-SUBSTITUTED CYANINE AND RED SHIFT TRIAZOLE DYES FUJI PHOTO FILM CO., LTD. (JP) 1979-02-06 US disclosed
US-4046572-A SILVER HALIDE PHOTOGRAPHIC LIGHT SENSITIVE MATERIAL FUJI PHOTO FILM CO., LTD. (JA) 1977-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11452717-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof NAMPT, NAPRT, NNT ALDH1A1 1943/4885MAPT 369/4885KDM4E 3620/4885
US-20230116770-A1 SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF NAMPT, NAPRT, NNT ALDH1A1 1943/4885MAPT 369/4885KDM4E 3620/4885
US-20050113566-A1 Inhibitors of C-FMS kinase ALK, TYRO3, PDGFRB ALDH1A1 2507/4885MAPT 4732/4885KDM4E 2647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.